Diverging detection limits of immunochemical tests for occult blood underline the necessity of standardization and quality assurance;Unterschiedliche Nachweisgrenzen immunologischer Tests auf Blut im Stuhl unterstreichen die Notwendigkeit der Standardisierung und Qualitätssicherung

Zeitschrift fur Gastroenterologie

Volumn 54, Issue 4, 2016, Pages 299-303

  Lüthgens, Kai ^a   Albert, S ^a   Brenner, H ^b  

^a Laboratory Prof Gisela Enders and Colleagues   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

colorectal adenoma; colorectal cancer; lower gastrointestinal bleeding

Indexed keywords

ARTICLE; COLONOSCOPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; HEALTH CARE QUALITY; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOCHEMISTRY; LIMIT OF DETECTION; OCCULT BLOOD TEST; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; GERMANY; IMMUNOASSAY; OCCULT BLOOD; PRACTICE GUIDELINE; PROCEDURES; REPRODUCIBILITY; STANDARDS;

HEMOGLOBIN;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GERMANY; HEMOGLOBINS; HUMANS; IMMUNOASSAY; OCCULT BLOOD; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84964940002     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0041-106854     Document Type: Article

References (18)

1. Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013; Available from: http://globocan.iarc.fr zuletzt aufgerufen am 8.2.2015
2. Hewitson P., Glasziou P., Watson E. et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol: 2008; 103 1541 1549
3. Scholefeld J. H., Moss S. M., Mangham C. M. et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut: 2012; 61 1036 1040
4. Shaukat A., Mongin S. J., Geisser M. S. et al. Long-term mortality after screening for colorectal cancer. N Engl J Med: 2013; 369 1106 1114
5. Sieg A., Scheida M., John M. R. et al. Validity of new immunological fecal hemoglobin and albumin tests in detecting colorectal neoplasms. An endoscopy controlled study. Z Gastroenterol: 1998; 36 485 490
6. Sieg A., Hertel A., John M. R. et al. Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test. Eur J Cancer Prev: 1998; 7 279 285
7. Brenner H., Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer: 2013; 49 3049 3054
8. Vart G., Banzi R., Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med: 2012; 55 87 92
9. Quintero E., Castells A., Bujanda L. et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med: 2012; 366 697 706
10. European guidelines for quality assurance in colorectal cancer screening and diagnosis, first edition. http://www.kolorektum.cz/res/file/guidelines/CRC-screening-guidelines-EC-2011-02-03.pdf zuletzt aufgerufen am 14.3.2015
11. Hundt S., Haug U., Brenner H. Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection. Ann Intern Med: 2009; 150 162 169
12. Arbeitsgemeinschaft der medizinisch-wissenschaftlichen Fachgesellschaften Kolorektales Karzinom. S3-Leitlinie. 2013; AWMF-Registernummer: 021/007OL. Version 1.0
13. Brenner H., Haug U., Hundt S. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer: 2010; 127 1643 1649
14. Möslein G., Schneider C., Theilmeier A. et al. Evaluierung der statistischen Kennwerte verschiedener kommerziell erhältlicher Stuhltests. Dtsch Med Wochenschr: 2010; 135 557 562
15. Hoepfner N., Shastri Y. M., Hanisch E. et al. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Aliment Pharmacol Ther: 2006; 23 145 154
16. Tao S., Brenner H. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening. Eur J Cancer Prev: 2013; 22 305 310
17. Brenner H., Hoffmeister M., Stock C. Qualitätssicherung in der Routine ist notwendig und gut realisierbar. Dtsch Arztebl: 2014; 111 A842 A843
18. Yamamoto M., Nakama H. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology: 2000; 47 396 399